Randall J. Bateman
Randall J. Bateman, MD, is a prominent neurologist and the Charles F. and Joanne Knight Distinguished Professor of Neurology at Washington University in St. Louis. He is known for his research in Alzheimer's disease, particularly focusing on its genetic aspects and the development of potential treatments. Recently, he was in the news for leading a clinical trial that demonstrated an experimental drug's potential to delay the onset of Alzheimer's symptoms in individuals with a high genetic risk for the disease.
Not in the pool (under ¢1).
Recent news mentions
Co-senior author Randall J. Bateman, MD, noted that in clinical practice today, there is not an easy or accessible measure of Alzheimer’s tangles and dementia.
New Alzheimer's blood test could be used to stage dementia, study finds
United States· 2025-04-01
Randall J. Bateman is the principal co-author of the study and a professor at the University of Washington.
Un test en sangre diagnostica el Alzheimer y mide el grado de avance de la enfermedad
Bolivia· 2025-04-01
Randall J. Bateman is the co-lead author of the study and a professor at the University of Washington.
Un simple análisis de sangre podría diagnosticar el Alzheimer y su grado de avance - Ciencia
Paraguay· 2025-03-31
Senior author Randall J. Bateman, MD, the Charles F. and Joanne Knight Distinguished Professor of Neurology at WashU Medicine, discussed the study's findings.
Experimental drug could help prevent Alzheimer's in certain population: studyUnited States· 2025-03-22
